Mutations in muscle phosphofructokinase gene.
Mutations in the muscle phosphofructokinase gene (PFK-M) result in a metabolic myopathy characterized by exercise intolerance and compensated hemolysis. PFK deficiency, glycogenosis type VII (Tarui disease) is a rare, autosomal, recessively inherited disorder. Multiple mutations, including splicing defects, frameshifts, and missense mutations, have recently been identified in patients from six different ethnic backgrounds establishing genetic heterogeneity of the disease. There is no obvious correlation between the genotype and phenotypic expression of the disease. PFK-M deficiency appears to be prevalent among people of Ashkenazi Jewish descent. Molecular diagnosis is now feasible for Ashkenazi patients who share two common mutations in the gene; the more frequent is an exon 5 splicing defect, which accounts for approximately 68% of mutant alleles in this population.
Raben
N
N
Arthritis and Rheumatism Branch, National Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Sherman
J B
JB
D002874:Chromosome Mapping; D006014:Glycogen Storage Disease Type VII / Q000175:diagnosis / Q000235:genetics*; D006801:Humans; D009132:Muscles / Q000201:enzymology*; D009154:Mutation; D010732:Phosphofructokinase-1 / Q000172:deficiency / Q000235:genetics*; D011110:Polymorphism, Genetic
D010732:Phosphofructokinase-1